Understanding how lung immune cells behave in different types of lung inflammation
Official title: Investigating Recruited Lung Macrophage Programming and Turnover in Self-Limited Versus Prolonged Lung Inflammation
Funded at University of Colorado Denver · NIH-10996080 · Data updated 2026-11-12
This study is looking at how certain immune cells in the lungs affect recovery from acute respiratory distress syndrome (ARDS), helping us understand why some people get better quickly while others struggle longer, with the hope of finding better treatments for everyone affected.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | August 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $53,974 |
| NIH project number | 5F30HL167581-02 |
| Project ID | NIH-10996080 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with acute respiratory distress syndrome or related lung injuries.
✕Less likely to help
Patients with chronic lung conditions unrelated to ARDS may not benefit from this research.
What this research studies
This research investigates the role of lung macrophages in acute respiratory distress syndrome (ARDS), a serious condition characterized by severe lung inflammation. It aims to understand why some patients recover quickly while others experience prolonged inflammation and potential lung damage. By analyzing specific immune cell behaviors and their genetic profiles using advanced techniques like single-cell RNA sequencing, the study seeks to identify factors that contribute to these varying outcomes. The findings could help in developing targeted therapies for patients suffering from ARDS.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with ARDS, potentially reducing mortality and long-term lung damage.
How similar studies have gone: Previous research has shown promising results in understanding immune cell behavior in lung inflammation, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of Colorado Denver
Aurora, United States Active
Researchers
- Principal investigator: King, Emily Mertens — University of Colorado Denver
- Study coordinator: King, Emily Mertens
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.